From Our Writers

Home prices in cities with easy access to adult-use cannabis dispensaries have risen on average by 8.4 percent since 2014.

Three wide-ranging medical cannabis-related bills — one expanding access to the state’s restrictive program, one related to FDA medical cannabis trials, and another adding cancer and irritable bowel disease to the qualifying conditions list — have failed in the Tennessee legislature.

Mass Alternative Care in Chicopee, Massachusetts is set to receive Hampden County’s first adult-use cannabis business license; the company will sell medical and adult-use cannabis products out of the same building.

President Trump’s Attorney General said on Wednesday he would prefer the proposed STATES Act, which would allow states to set their own cannabis policies, over the current disconnect between state and federal cannabis laws.

The FDA last month warned three U.S. companies who were distributing hemp-derived CBD products that their products violate federal law.

Cannabis prices in Canada’s regulated and unregulated markets alike have risen on average by 17 percent since legalization took place last year.

A bi-partisan Massachusetts proposal would subject unlicensed cannabis sellers to a “foregone tax revenue assessment,” which would bill illegal operators based on the “estimated forgone tax revenue” resulted from their unregulated sales.

Connecticut lawmakers have advanced three cannabis bills out of committee: one to allow possession and expunge low-level possession charges, one establishing a regulated marketplace, and one to ensure employers can bar cannabis use from the workplace and to create a DUI test for cannabis.

Recent changes to New Mexico’s medical cannabis rules could potentially grant access to inmates throughout the state.

International consumer goods giant Unilever will push CBD-infused deodorant products to store shelves under its brand Schmidt’s Naturals later this year.

Senate Majority Leader Mitch McConnell says he will support a legislative fix for issues with federal industrial hemp rules.

A Florida House proposal to legalize and regulate adult-use cannabis will be refused a hearing, debate, and vote by legislative leaders.

Medical cannabis patients in Minnesota have reported a “significant reduction” in the severity of their cancer symptoms.

Florida agriculture regulators have finalized rules for the manufacturing and sales of medical cannabis-infused edible products; the rules must also be considered by health regulators, however, before becoming law.

At least two Canadian financial institutions are turning away U.S.-based cannabis companies due to the plant’s ongoing federal prohibition there.

Indiana farmers will get to participate in a proposed hemp advisory committee if the crop is successfully legalized in the state.

Texas hemp regulators plan to enforce just the minimal federal standards to help farmers and foster the industry’s growth.

New rules in New Mexico will remove some criminal penalties for cannabis possession while another new law offers critical changes to the state’s medical cannabis program.

Under decriminalization rules passed April 1, adults in Israel will no longer be prosecuted for simple home growing and low-level cannabis possession.

A recent budget amendment in Washington state aims to give police departments cannabis tax dollars to help combat drug addiction in homeless communities.

Colorado Gov. Jared Polis is expected to sign the state’s new cannabis-for-autism bill as lawmakers consider additional reforms, including options for social use and cannabis delivery businesses.

Georgia lawmakers have approved a bill establishing comprehensive medical cannabis reforms; the governor is expected to sign the bill into law.

Vireo Health has acquired Massachusetts licensed cannabis company Mayflower Botanicals; it is Vireo’s first acquisition in a state with an adult-use program.

The FDA is planning a public hearing next month to consider the safety, manufacturing, product quality, marketing, labeling, and sale of federally regulated CBD products.